enterpreneurship management

A SEMINAR ON PHARMA ENTERPRENEURSHIP MANAGEMENT: 

BY: Bhavana. S M. Pharmacy (Pharmaceutics) 1 st year,2 nd semester, Roll no.256311886002, Priyadarshini College Of Pharmaceutical Sciences 1 A SEMINAR ON PHARMA ENTERPRENEURSHIP MANAGEMENT

PowerPoint Presentation: 

Glenn Saldanha Glenmark Pharmaceuticals is one company which has gone against the tide and etched it’s name on a global platform. Glenmark Pharmaceuticals was founded by Gracias Saldanha in 1977. He started his career as a medical representative and worked his way up through the ranks in MNC pharma companies like Abbott Laboratories, Aristo, E Merck from 1964 to 1977. 2

Cont…: 

Cont… Even before starting Glenmark, he had 20-25 years of experience in the pharma industry. Before joining Glenmark, Glenn had stints with Eli Lilly and Price Water house Coopers after completing his bachelors in pharmacy from Mumbai University and MBA from Leonard Stern School of Business, New York University. He retired in 2000 and his son, Glenn Saldanha, MD and CEO Glenmark Pharmaceuticals took charge of the company as an Executive Director. Glenmark was started as a small bulk drugs firm with 99 percent domestic focus, and when Glenn came on board, it was decided to revamp its business strategy and build it into complete research driven organization. 3

Cont..: 

Cont.. In 1979, Gracias Saldanha company entered the anti-fungal market, where competition was less due to the relatively smaller market size, by introducing Candid Cream. During 1987,  the Company started a Research and Development Department at it's Nasik factory. Saldanha is estimated to be worth $675 billion as of 2011 by Forbes and was ranked as the 77th richest person in world. Glenmark Pharmaceuticals, under the able leadership of Saldanha, is making a foray in the European market. All along, the company has been one of the frontrunners in the industry. Even in the current race for newer acquisitions and mergers, it is seen to have held its fort ably. Undeniably, all this has been possible because of one man - Saldanha. 4

Strategies : 

Strategies Glenmark is one company which has been successful both in innovation as well as in generics. In a very short time span, they were able to build a very sizeable and strong US generics business. "So because of that Saldanha thought he could create a global innovative platform out of India. And he still come from that belief that one can truly create an innovative company out of India.“ Hence, Gracias and Glenn's adopted the Novartis-Sandoz model of spinning off the generics business, so that the generics company (Glenmark Generics) focuses on generic and the parent company on innovation. 5

Accolades: 

Accolades “ Young Business Leader of the Year” by UK Trade & Investment in Oct‟09. India‟s second most Valuable CEO –Business World Dec‟08. “21 leaders to watch out for in the 21st Century” -Business Today – Jan‟08. SCRIP, the leading pharmaceutical magazine in the world Crowns Glenmark as the “Best Pharma Company in the World – SME” and the “Best Company in Emerging Markets” at the SCRIP Awards 2008 in London. Glenmark is the only Indian company to have received this prestigious recognition 6

PowerPoint Presentation: 

Dr. Desh Bandhu Gupta One pharma company that stood the test of time and has emerged as one of the strong contenders to be the best in time and future is Lupin. Lupin, headed by Dr. Desh bandhu Gupta, has established itself as one of the leading Indian pharmaceutical companies. The modus operandi of the company, under Dr. Gupta is characterized by frequent and ambitious forays into foreign markets. 7

Dr. Desh Bandhu Gupta: 

Dr. Desh Bandhu Gupta An honorary Doctor of philosophy with a Master's degree in Chemistry, Dr. Gupta started his career as an academician teaching chemistry at Birla Institute of Science and Technology, Pilani in Rajasthan. After his teaching stint got terminated, he founded Lupin in 1968. Since then he has constantly been at the helm of affairs in the company. He has seen the company through many ups and downs and has been instrumental in steering the company towards the forefront of the Indian Pharmaceutical industry. Dr. Gupta has shown an ample measure of adeptness in striking difficult-looking deals. His special ability is cited by analysts as the salient reason behind the company's successful performance in foreign markets 8

Strategy : 

Strategy Desh Bandhu Gupta is the Indian Businessman and a billionaire business tycoon. In 2010, Forbes has estimated his net worth to be US $ 1.5 Billion making him India’s Top 50 richest persons. As a part of strategy, Dr. Gupta stepped down as the company's Managing Director and retained only the rank of the Chairman. He cited the difficulty to micro-manage the company as the reason behind his much-discussed stepping down. It is not difficult to understand that the move was actually aimed at successfully negotiating the ever-changing product patent laws. Today Lupin has achieved the distinction of not only becoming India's fifth largest pharma major and largest producer of tuberculosis drugs but also one of the fastest growing generic player in the world specifically in advanced markets such as the US and Japan. 9

Cont..: 

Cont.. With his vision to contribute to nation-building and social development, Mr. Gupta set up the Lupin Human Welfare & Research Foundation (LHWRF) on 2 October 1988. LHWRF has now succeeded in revitalizing and redefining life in 2,200 villages across five states, touching the lives of over two million people. He strongly believes and says that “ We must not look back at our milestones but look forward to new challenges and goals with a resolute determination to seek out excellence in all that we do. Quality products and services are no longer the hallmark of success. They are simply expected in today’s increasingly demanding marketplace”. 10

Accolades: 

Accolades Dr. Gupta’s noteworthy achievements can be attributed to both his spiritual and scientific temperament. He is a trustee of the Global Vipassana Foundation and is also the Chairman of the managing committee of ISKCON. He was felicitated with the Lifetime Achievement Award at the Pharma Leadership Summit 2009 for his contribution to the Indian pharma industry. 11

References : 

References http://www.forbes.com/lists/2009/77/india-billionaires-09_Gracias-Saldanha_8GY4.html?partner=contextstory http://www.expresspharmaonline.com/20090131/anniversaryspecial03.shtml http://www.glenmarkpharma.com/common/pdf/Glenn_Saldanha-Profile.pdf http://www.expresspharmaonline.com/20090131/anniversaryspecial08.shtml http://www.india-inc.in/Dr-Desh-bandhu-Gupta.html 12